Skip to content

Implementing a postoperative prospective surveillance and early intervention for reducing the risk of the breast cancer related lymphedema

Implementing a postoperative prospective surveillance and early intervention for reducing the risk of the breast cancer related lymphedema

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060685
Enrollment
Unknown
Registered
2022-06-07
Start date
2022-06-22
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer related lymphedema

Interventions

regular surveillance group:The patients were prospectively monitored at regular intervals before surgery and at 3, 6, 9, and 12 months postoperatively. Assessments included the extracellular fluid res
routine monitoring group:Postoperative health education was provided to patients at 3, 6, 9, and 12 months after surgery, covering dietary guidance, rehabilitation exercise instruction, stress managem

Sponsors

Peking University Cancer Hospital & Institute
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Pathological diagnosis of primary breast cancer; 2. After sentinel lymph node biopsy or axillary lymph node puncture, axillary lymph node metastasis was pathologically confirmed and axillary lymph node dissection was planned; 3. Patients to be followed up regularly in our hospital for at least 2 years; 4. Aged 18-70 years; 5. Clear mind and can communicate normally; 6. Voluntary participation in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with previous history of breast cancer; 2. Patients with bilateral breast cancer; 3. Patients with lymphedema; 4. Patients with recurrence and metastasis; 5. Patients with limb dysfunction, thrombosis and infection; 6. Patients with chronic kidney disease, congestive heart failure and pregnancy; 7. Patients with built-in pacemakers; 8. The general condition is poor, and the patient can not tolerate pressure treatment.

Design outcomes

Primary

MeasureTime frame
clinical lymphedema;

Secondary

MeasureTime frame
quality of life;psychological status;Range of motion of the affected limb;Assessment of limb function;

Countries

China

Contacts

Public ContactYu Xinying

Peking University Cancer Hospital & Institute

cindy1104@sohu.com+86 136 9107 2928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026